Jolanta Szelachowska

682 total citations
34 papers, 508 citations indexed

About

Jolanta Szelachowska is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jolanta Szelachowska has authored 34 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Jolanta Szelachowska's work include Cancer Cells and Metastasis (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Breast Cancer Treatment Studies (5 papers). Jolanta Szelachowska is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Breast Cancer Treatment Studies (5 papers). Jolanta Szelachowska collaborates with scholars based in Poland, Czechia and Türkiye. Jolanta Szelachowska's co-authors include Rafał Matkowski, Jan Kornafel, Iwona Gisterek, Agnieszka Hałoń, Adam Maciejczyk, B. Szynglarewicz, Michał Jeleń, Paweł Surowiak, Aleksandra Łacko and Marek Pudełko and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jolanta Szelachowska

31 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolanta Szelachowska Poland 12 247 208 117 113 61 34 508
Valérie Dessirier France 12 125 0.5× 157 0.8× 158 1.4× 84 0.7× 74 1.2× 14 528
Julie Madden United Kingdom 9 212 0.9× 214 1.0× 110 0.9× 82 0.7× 49 0.8× 14 502
Nina Waldburger Germany 13 149 0.6× 201 1.0× 63 0.5× 119 1.1× 94 1.5× 19 456
Abha Soni United States 10 290 1.2× 134 0.6× 134 1.1× 107 0.9× 139 2.3× 23 519
Lucia Gelao Italy 11 291 1.2× 160 0.8× 193 1.6× 203 1.8× 110 1.8× 16 607
Maria Cardenas United States 6 214 0.9× 266 1.3× 46 0.4× 198 1.8× 117 1.9× 14 496
M.T. Allende Spain 13 165 0.7× 184 0.9× 99 0.8× 81 0.7× 150 2.5× 25 589
Shozo Hojo Japan 10 335 1.4× 184 0.9× 269 2.3× 80 0.7× 89 1.5× 23 612
S.N. Kehlet Denmark 12 122 0.5× 114 0.5× 59 0.5× 100 0.9× 60 1.0× 17 386
Jennifer A. Grabowsky United States 12 274 1.1× 389 1.9× 67 0.6× 75 0.7× 104 1.7× 29 634

Countries citing papers authored by Jolanta Szelachowska

Since Specialization
Citations

This map shows the geographic impact of Jolanta Szelachowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Szelachowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Szelachowska more than expected).

Fields of papers citing papers by Jolanta Szelachowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Szelachowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Szelachowska. The network helps show where Jolanta Szelachowska may publish in the future.

Co-authorship network of co-authors of Jolanta Szelachowska

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Szelachowska. A scholar is included among the top collaborators of Jolanta Szelachowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Szelachowska. Jolanta Szelachowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pawlak, Edyta, Andrzej Tukiendorf, Jolanta Szelachowska, et al.. (2022). Socioeconomic aspect of breast cancer incidence and mortality in women in Lower Silesia (Poland) in 2005–2014. Postępy Higieny i Medycyny Doświadczalnej. 76(1). 62–70. 1 indexed citations
2.
Farooqi, Ammad Ahmad, Rükset Attar, Maria Gazouli, et al.. (2022). Regulation of ROCK1/2 by long non‑coding RNAs and circular RNAs in different cancer types (Review). Oncology Letters. 23(5). 159–159. 9 indexed citations
3.
Kološtová, Katarína, et al.. (2022). Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells. Cancer Immunology Immunotherapy. 71(12). 2901–2911. 8 indexed citations
4.
Błaszczyk, Jerzy, et al.. (2019). The effect of the population-based cervical cancer screening program on 5-year survival in cervical cancer patients in Lower Silesia. Advances in Clinical and Experimental Medicine. 28(10). 1377–1383. 2 indexed citations
5.
Matkowski, Rafał, et al.. (2017). Influence of the MCM7 Protein Expression on Oral Cancer Patient Prognosis, Using Different Methods of the Measurement. International Journal of Radiation Oncology*Biology*Physics. 99(2). E388–E388.
6.
Tarkowski, Radosław, et al.. (2016). Patient’s Education Before Mastectomy Influences the Rate of Reconstructive Surgery. Journal of Cancer Education. 32(3). 537–542. 10 indexed citations
7.
8.
Bobek, Vladimír, Rafał Matkowski, R Gürlich, et al.. (2014). Cultivation of circulating tumor cells in esophageal cancer. Folia Histochemica et Cytobiologica. 52(3). 171–177. 46 indexed citations
9.
Maciejczyk, Adam, Jolanta Szelachowska, Bogdan Czapiga, et al.. (2013). Elevated BUBR1 Expression Is Associated with Poor Survival in Early Breast Cancer Patients. Journal of Histochemistry & Cytochemistry. 61(5). 330–339. 36 indexed citations
10.
Maciejczyk, Adam, et al.. (2012). [Analysis of BCRP expression in breast cancer patients].. PubMed. 83(9). 681–7. 4 indexed citations
11.
Maciejczyk, Adam, Jolanta Szelachowska, Rafał Matkowski, et al.. (2012). Elevated nuclear YB1 expression is associated with poor survival of patients with early breast cancer.. PubMed. 32(8). 3177–84. 21 indexed citations
12.
Maciejczyk, Adam, Jolanta Szelachowska, B. Szynglarewicz, et al.. (2011). CD46 Expression is an Unfavorable Prognostic Factor in Breast Cancer Cases. Applied immunohistochemistry & molecular morphology. 19(6). 540–546. 43 indexed citations
13.
Gisterek, Iwona, Agnieszka Hałoń, Rafał Matkowski, et al.. (2011). Prognostic role of c-met expression in breast cancer patients. Reports of Practical Oncology & Radiotherapy. 16(5). 173–177. 12 indexed citations
14.
Gisterek, Iwona, Rafał Matkowski, Agnieszka Hałoń, et al.. (2010). Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.. Folia Histochemica et Cytobiologica. 48(1). 78–83. 4 indexed citations
15.
Gisterek, Iwona, et al.. (2010). [The importance of determining the prognostic marker YKL-40 in serum and tissues].. PubMed. 28(168). 505–8. 10 indexed citations
16.
Matkowski, Rafał, Iwona Gisterek, Agnieszka Hałoń, et al.. (2009). The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.. PubMed. 29(7). 2445–51. 96 indexed citations
17.
Gisterek, Iwona, Rafał Matkowski, Aleksandra Łacko, et al.. (2009). Serum Vascular Endothelial Growth Factors A, C and D in Human Breast Tumors. Pathology & Oncology Research. 16(3). 337–344. 28 indexed citations
18.
Szynglarewicz, B., Rafał Matkowski, Agnieszka Hałoń, et al.. (2009). Mastectomy Approach With Y-Shaped Incision. International Journal of Gynecological Cancer. 19(8). 1454–1458. 10 indexed citations
19.
Szelachowska, Jolanta, Michał Jeleń, & Jan Kornafel. (2006). Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer.. PubMed. 26(5B). 3871–6. 11 indexed citations
20.
Szelachowska, Jolanta & Michał Jeleń. (2004). Laminin, Her2/neu and Ki-67 as prognostic factors in non-small cell lung cancer.. PubMed. 49. 256–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Dessirier Breakdown of academic impact, for papers by Julie Madden Breakdown of academic impact, for papers by Nina Waldburger Breakdown of academic impact, for papers by Abha Soni Breakdown of academic impact, for papers by Lucia Gelao Breakdown of academic impact, for papers by Maria Cardenas Breakdown of academic impact, for papers by M.T. Allende Breakdown of academic impact, for papers by Shozo Hojo Breakdown of academic impact, for papers by S.N. Kehlet Breakdown of academic impact, for papers by Jennifer A. Grabowsky
Rankless by CCL
2026